ICONYC labs
ICONYC labs is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at ICONYC labs.
ICONYC labs is a company.
Key people at ICONYC labs.
Key people at ICONYC labs.
ICONYC Labs is a New York City-based value-add investor and accelerator program designed for early-stage Israeli tech startups aiming to expand globally, particularly into the US market.[1][5][6] It combines elements of traditional accelerators with customized business acceleration, funding support, and operations assistance in exchange for common equity (averaging about 8%), focusing on Seed and Series A stages in sectors like technology, healthcare, AI/ML, entertainment, edtech, and biotech.[1][2][4] With 25 investments to date, including recent ones like Hunterz (Seed VC, 2019) and Skyline Robotics ($3M Seed VC, 2018), ICONYC Labs acts as a strategic partner rather than a standard accelerator, offering tailored six-month programs without one-size-fits-all events like Demo Day.[1][2]
The firm's mission emphasizes hands-on guidance for founders with breakthrough technologies and high-growth potential, leveraging NYC's network to shorten time-to-market and foster long-term scaling.[2][5] Its investment philosophy prioritizes disruptive startups via check sizes of $500K–$2M, providing not just capital but strategic advice, mentor access, and customized weekly plans refined for each company's needs.[1][2][4]
ICONYC Labs was founded by Eyal Bino (39 at launch), angel investor/adviser Abecassis (49), and Mirsky (35), who connected through the Global Innovator Program of the Worldwide Investor Network—a three-month accelerator for high-potential foreign companies in high-tech, ecommerce, ad-tech, mobile, and mobile health.[1] Launched around 2015 (based on earliest noted investments like a debt deal in August 2015), the firm evolved from this network into a specialized NYC-based program for Israeli startups, initially as a four-to-six-month go-to-market accelerator.[1][5][6]
Key pivots include shifting from rigid accelerator models to hyper-personalized support, borrowing traditional elements but amplifying them for global positioning—such as ditching Demo Days for need-specific funding timelines.[1] Early traction came via investments in diverse Israeli tech firms, building a portfolio of 25 companies and establishing NYC as a bridge for Israel-US market entry.[1][4]
ICONYC Labs rides the trend of cross-border expansion for Israeli startups, capitalizing on Israel's "Startup Nation" status in deep tech (AI, robotics, cybersecurity, biotech) amid surging US-Israel tech synergies.[1][4] Timing aligns with post-2015 growth in Israeli VC inflows and NYC's emergence as a startup hub, shortening US go-to-market for firms facing regulatory, network, and scaling hurdles.[1][5][6]
Market forces favoring it include rising demand for tailored accelerators amid traditional models' limitations, plus NYC's proximity to US capital and talent pools.[2][4] It influences the ecosystem by bridging ~25 portfolio companies to global success, fostering Israel-US talent flows, and proving value-add models outperform generic programs—amplifying Israeli innovation's impact on worldwide tech/healthcare disruption.[1][2]
ICONYC Labs is poised to deepen its role in Israel-US tech corridors, potentially expanding to Series B or non-Israeli founders as AI/biotech booms post-2025.[2] Trends like AI scaling, medtech regulation easing, and remote acceleration will shape it, with influence evolving via larger funds or LP partnerships leveraging its 25-investment track record.[1][2]
As a pioneer in customized value-add investing, ICONYC Labs exemplifies how strategic NYC-Israel bridges propel early-stage startups to global contention—primed for outsized returns in the next decade.[1][5]
